Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Exostosis
ADR ID BADD_A01561
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.02      Bone disorders (excl congenital and fractures)
15.02.04      Bone disorders NEC
15.02.04.005      Exostosis
Description A disorder characterized by non-neoplastic overgrowth of bone. [CTCAE] Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component. [MeSH]
MedDRA Code 10015688
MeSH ID D005096; D015576; D005096; D054850; D005096; D036982; D005096
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bone hypertrophy | Bone spur | Calcaneal spur | Exostosis | Exostosis of orbit | Exostosis of unspecified site | Foot exostosis | Hyperostosis | Hyperostosis of skull | Heel exostosis | Osteophytosis | Haglund deformity | Central osteophyte | Trochanteric osteophyte | Exostoses
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02392Zoledronic acid0.059048%
BADD_D02426Ibandronate0.001423%
BADD_D02464Fingolimod0.004632%
The 2th Page    First    Pre   2    Total 2 Pages